Literature DB >> 29845215

Pien Tze Huang ameliorates DSS‑induced colonic inflammation in a mouse colitis model through inhibition of the IL‑6/STAT3 pathway.

Li Li1, Aling Shen1, Jianfeng Chu1, Thomas J Sferra2, Senthilkumar Sankararaman2, Xiao Ke3, Youqin Chen2, Jun Peng1.   

Abstract

Interleukin‑6 (IL‑6)/signal transducer and activator of transcription 3 (STAT3) pathway plays essential roles in the development of inflammatory diseases including ulcerative colitis (UC). Therefore, suppression of IL‑6/STAT3 signaling provides a promising therapeutic strategy in UC. Pien Tze Huang (PZH), a well‑known traditional Chinese formula, has been used in China and Southeast Asia for centuries as a folk remedy for various inflammatory diseases. However, the molecular mechanisms of its anti‑inflammatory effects remain to be elucidated. In the present study, we generated a mouse colitis model by using dextran sulfate sodium (DSS) and evaluated the therapeutic efficacy of PZH against UC by observing the clinical manifestations. We found that PZH obviously alleviated DSS‑induced colitis symptoms, including body weight loss, rectal bleeding and stool consistency. In addition, administration of PZH profoundly prevented DSS‑induced colon shortening, and ameliorated colonic histopathological changes such as mucosal ulceration, infiltration of inflammatory cells, crypt distortion and hyperplastic epithelium. Moreover, PZH markedly inhibited the serum level of the inflammatory biomarker serum amylase A (SAA) in UC mice. Furthermore, PZH treatment significantly inhibited DSS‑induced expression of IL‑6 in colon tissues. Finally, the increased phosphorylation level of STAT3, induced either by DSS in experimental mice or by IL‑6 in the differentiated human colorectal carcinoma cells, was significantly suppressed by PZH. These results suggest that the inhibition of IL‑6/STAT3 signaling is a potential mechanism by which PZH is used in the treatment of UC.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29845215     DOI: 10.3892/mmr.2018.9051

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  7 in total

Review 1.  Role of interleukin-6-mediated inflammation in the pathogenesis of inflammatory bowel disease: focus on the available therapeutic approaches and gut microbiome.

Authors:  Arshia Shahini; Ali Shahini
Journal:  J Cell Commun Signal       Date:  2022-09-16       Impact factor: 5.908

Review 2.  Inflammatory bowel disease: an overview of Chinese herbal medicine formula-based treatment.

Authors:  Shuo Yuan; Qi Wang; Jiao Li; Jia-Chen Xue; You Li; Huan Meng; Xiao-Ting Hou; Ji-Xing Nan; Qing-Gao Zhang
Journal:  Chin Med       Date:  2022-06-18       Impact factor: 4.546

3.  Integrating Pharmacology and Microbial Network Analysis with Experimental Validation to Reveal the Mechanism of Composite Sophora Colon-Soluble Capsule against Ulcerative Colitis.

Authors:  Yuxuan Ding; Mingjun Chen; Qiying Wang; Lu Gao; Yang Feng; Shida Wang; Zitian Song; Zhanqi Tong
Journal:  Evid Based Complement Alternat Med       Date:  2020-04-20       Impact factor: 2.629

Review 4.  Pien Tze Huang (PZH) as a Multifunction Medicinal Agent in Traditional Chinese Medicine (TCM): a review on cellular, molecular and physiological mechanisms.

Authors:  Zhiliang Chen
Journal:  Cancer Cell Int       Date:  2021-03-03       Impact factor: 5.722

5.  Case report: Treatment with Pien-Tze-Huang for prolonged positive SARS-CoV-2 test results in COVID-19 patients: A report of five cases.

Authors:  Yujiao Zheng; Jinbo Cheng; Chengjuan Gu; Mingzhong Xiao; Zuoyu Shao; Linhua Zhao; Xiaolin Tong
Journal:  Front Med (Lausanne)       Date:  2022-08-09

6.  Pien-Tze-Huang alleviates CCl4-induced liver fibrosis through the inhibition of HSC autophagy and the TGF-β1/Smad2 pathway.

Authors:  Yuqin Zhang; Liping Hua; Chunfeng Lin; Mingzhou Yuan; Wei Xu; Anand Raj D; Baskar Venkidasamy; Carlos L Cespedes-Acuna; Shivraj Hariram Nile; Guohong Yan; Haiyin Zheng
Journal:  Front Pharmacol       Date:  2022-09-16       Impact factor: 5.988

Review 7.  Therapeutic Potential of Pien-Tze-Huang: A Review on Its Chemical Composition, Pharmacology, and Clinical Application.

Authors:  Lili Huang; Yiping Zhang; Xiaoqin Zhang; Xiuping Chen; Yitao Wang; Jinjian Lu; Mingqing Huang
Journal:  Molecules       Date:  2019-09-09       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.